Long-Term Outcomes Following HBOT

Part of paid clinical trials in Boise, Idaho.

Sponsor: Summit Hyperbarics and Wellness
Study ID: NCT07732374
Phase: PHASE2
Status: Recruiting

Apply to this trial

Conditions

Post-Concussive Symptoms
Post-Traumatic Stress Disorder
Traumatic Brain Injury

Eligibility Criteria

Sex: ALL
Age: 18 Years - N/A
Healthy Volunteers: Not accepted

Interventions

Hyperbaric Oxygen Therapy (HBOT) — DRUG
Hyperbaric Oxygen Therapy (HBOT): Participants will receive 100% medical oxygen (USP) administered under hyperbaric conditions at 2.0 atmospheres absolute (ATA) for 60 minutes with a scheduled air break over 40 treatment sessions.

Study Details

This study is designed to better understand the long-term effects of hyperbaric oxygen therapy (HBOT). Our goal is to determine whether improvements after treatment are maintained over time and whether additional benefits appear months after treatment has ended. We will evaluate changes in cognitive function, mental health, and daily functioning to help strengthen the scientific evidence supporting the use of HBOT and guide future treatment recommendations.

Key Dates

First listed: Jul 28, 2026
Start date: Jun 18, 2026
Status verified: Jun 2026
Primary completion: Jun 18, 2027
Completion: Jun 18, 2027

Study Design

Enrollment: 35 participants (estimated)
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Arms

Experimental: HBOT Follow-Up Cohort
Veterans who previously completed a standardized Hyperbaric Oxygen Therapy (HBOT) treatment protocol and undergo follow-up assessments approximately 12 weeks after their final treatment session to evaluate the long-term durability of cognitive, psychological, and quality-of-life outcomes.